E-Posters-Intravaginal non-Ablative Radiofrequency Treatment for Genitourinary Syndrome of Menopause

Intravaginal non-Ablative Radiofrequency Treatment for Genitourinary Syndrome of Menopause - Patricia Lordelo

Pdf Summary

The study aims to investigate the clinical response and adverse effects of intravaginal non-ablative radiofrequency (RF) treatment for genitourinary syndrome of menopause (GSM). The research followed the principles of the Helsinki Declaration and was registered on clinicaltrial.gov. The pilot study included women up to 65 years old with established menopause and symptoms of vulvovaginal atrophy. Participants were excluded if they used pacemakers, hormonal replacement, had metallic prostheses in the pelvic region, or had a vaginal infection. The treatment involved five RF sessions with a seven-day interval between them using a capacitive electrical transfer method. Clinical response criteria were assessed at the beginning and end of each session and at 7 days and one month after the end of treatment. A likert scale was used to measure participant satisfaction with the treatment. Adverse effects were monitored. Eleven women completed the protocol, and after one and three months of treatment, they reported reduced clinical symptoms and were satisfied with the clinical response. No adverse effects were reported. The preliminary result is promising, but larger clinical trials are needed to increase the validity of the study.

Meta Tag

Concept Intravaginal Radiofrequency

Concept Vaginal Atrophy

Concept Safety

Concept Adverse Effect

Concept Dyspareunia

Keywords

intravaginal non-ablative radiofrequency treatment

genitourinary syndrome of menopause

clinical response

adverse effects

vulvovaginal atrophy

likert scale

participant satisfaction

reduced clinical symptoms

larger clinical trials

Helsinki Declaration

Intravaginal Radiofrequency

Vaginal Atrophy

Safety

Adverse Effect

Dyspareunia